Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Will a limited vaccine waiver limit future options?
As attempts to ring-fence markets and restrict access continue, will India and South Africa toe the WTO line?
WHO selects Biological E as mRNA technology recipient from WHO technology transfer hub
WHO and partners will work with the Indian government and Bio E to develop a roadmap and put in place the necessary training and…
NPPA increases prices of over 800 essential drugs
The ceiling prices, inclusive of Wholesale Price Index (WPI) at 10.76 per cent for the year 2021 over 2020, are applicable with…
NIH begins clinical trial evaluating second COVID-19 booster shots in adults
The trial aims to understand if different vaccine regimens—prototype and variant vaccines alone and in combinations—can broaden…
A seat at the table: Shaping the healthcare policy landscape
While trade agreements with Australia, the UK, Canada and Bangladesh are nearing completion, and discussions with the EU and…
‘The Lancet’ publishes phase-III data of ZyCoV-D
The results of the phase-I part of the phase-I/II clinical trial have already been published in the e-Clinical Medicine Journal of…
Biocon Biologics’ partner receives positive EU CHMP opinion for biosimilar human insulin for IV…
Celerity Pharma uses Biocon Biologics’ insulin drug substance to develop the product
Florida reaches $878 million opioid settlements with CVS, Teva and others
CVS will pay $484 million, Teva Pharma will pay $194.8 million, Abbvie Inc's Allergan unit will pay $134.2 million and Endo…
Express Pharma April 2022
India's Foremost Pharma & Biotech Magazine ~ Analytical Development Conclave 2022: Preparing For An Era Of Innovation
Fresenius agrees two acquisitions to bolster Kabi drugs unit
The German healthcare group said today it would acquire a 55 per cent stake in mAbxience, a maker of affordable biosimilar…